Recurrent Gliosarcoma: Clinical Trials

2 trials for Recurrent Gliosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Withdrawn 1

Follow Recurrent Gliosarcoma: new trials by email Literature Review of Recurrent Gliosarcoma trials Research Report on Recurrent Gliosarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma
Liothyronine, Lomustine, Methimazole - Recurrent Glioblastoma, Recurrent Gliosarcoma
Early Phase 1WithdrawnEmory University2021-10-202022-12-02
Vaccine Therapy in Treating Patients With Recurrent Glioblastoma
Laboratory Biomarker Analysis, Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine - Giant Cell Glioblastoma, Recurrent Glioblastoma
Early Phase 1CompletedMayo Clinic202013-11-272023-06-28

Narrower conditions

Glioblastoma (2)  ·  Gliosarcoma (2)

Broader conditions

Astrocytoma (2)  ·  Glioma (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Neoplasms, Nerve Tissue (2)  ·  Neoplasms, Neuroepithelial (2)  ·  Neuroectodermal Tumors (2)

Interventions

Lomustine (1)  ·  Methimazole (1)  ·  Triiodothyronine (1)

Sponsors

Emory University (1)  ·  Mayo Clinic (1)

Countries

United States (1)

Top investigators

Ian Parney (1)  ·  Jeffrey J. Olson, MD (1)

NIH funding

P30CA138292 (1)